Revenue
$14.2m
+7.6% ↑ vs $13.2m
A NZ$5.0m working-capital build ahead of the seasonally heavy 2H drove OCF from +NZ$2.1m to -NZ$5.4m and required NZ$13.0m of new borrowings.
Revenue context before the current result.
Operating profit margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY26 vs HY25
Revenue
$14.2m
+7.6% ↑ vs $13.2m
EBITDA
−$2.1m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net profit after tax
−$0.6m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
−$5.4m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Operating profit
−$0.9m
-12.5% ↓ vs −$0.8m
Profit before tax
−$2m
-33.3% ↓ vs −$1.5m
Cash and cash equivalents
$3.6m
-16.3% ↓ vs $4.3m
Total assets
$187.2m
-7.2% ↓ vs $201.8m
What changed
Operating cash flow turned from +NZ$2.1m to -NZ$5.4m, and capex rose 80% to NZ$1.8m (12.7% of revenue). To bridge the gap, gross borrowings rose 61.9% to NZ$34.0m and net debt nearly doubled to NZ$30.4m; cash slipped to NZ$3.6m from NZ$4.3m.
Revenue rose to NZ$14.2m from NZ$13.2m on what the release describes as record HY volumes, predominantly from Brazil (NZ$14.1m, 99.3% of revenue). EBITDA worsened to NZ$-2.1m from NZ$-0.5m and PBT widened to NZ$-2.0m from NZ$-1.5m. Total equity fell to NZ$125.5m from NZ$148.6m.
What matters
Operating working capital rose NZ$5.0m to NZ$48.5m and inventory built NZ$2.1m to NZ$48.8m, consistent with a seasonally weighted 2H selling period, but the resulting pre-lease FCF of NZ$-7.2m sits below the supplied historical HY range. This matters because prior HY working-capital builds have not consumed cash to this extent.
Leverage stepped up sharply. Gross borrowings rose to NZ$34.0m from NZ$21.0m and net debt nearly doubled to NZ$30.4m from NZ$16.7m. The NZ$13.0m of new debt exceeds the NZ$8.3m year-on-year FCF gap, suggesting funding was raised ahead of further 2H working-capital and inventory needs rather than just covering the HY shortfall.
Brazil now carries effectively the entire business. US revenue was NZ$0.1m against Brazil's NZ$14.1m. The release flags that the bulk of US sales are recognised in 2H26, so concentration may normalise across FY26, but the HY26 read-through to underlying earnings is single-geography.
Expectations
If a similar shape holds, FY26 revenue should materially exceed the HY annualisation. However, FY25 NPAT was NZ$-21.5m with only NZ$-0.1m booked in HY25, meaning effectively the entire FY25 loss landed in 2H.
No FY26 guidance, quantified 2H expectation, or stated target was provided. The seasonal shape means an HY26 loss does not by itself signal FY26 deterioration, but it also offers no early read on whether 2H26 will repeat the heavy 2H25 NPAT outcome.
Quality of result
PBT margin at -14.1% is at the upper edge of the supplied historical HY range (mean -17.5%), and EBITDA of NZ$-2.1m, while weaker than HY25, is broadly consistent with the company's HY loss pattern given second-half-weighted revenue. The effective tax rate of 70.0% is above the historical baseline (mean -16.3%) and reflects tax accounting on a small pre-tax loss; PBT is therefore the cleaner read on underlying operating performance.
Where the result looks lower quality is the cash side. The NZ$7.5m OCF swing, the 80% step-up in capex, and a pre-lease FCF position below the historical HY range together pushed equity down NZ$23.1m and total assets to NZ$187.2m, below the company's historical HY asset baseline of NZ$198.6m. These movements need to reverse meaningfully in 2H26 for FY26 cash and balance-sheet metrics to look comparable to recent years.
Unresolved
This briefing cannot assess management's specific 2H26 revenue, margin, or working-capital expectations because no quantitative forward guidance or target was disclosed in the release.
Chat
Ask follow-up questions about ArborGen Holdings's HY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
ArborGen Holdings Limited - Interim Report for the six months ended 30 September 2025
HY26 / financial reportArborGen Holdings Limited - Interim Results to 30 September 2025
HY26 / results announcementArborGen Holdings Limited - Interim Results to 30 September 2025
HY26 / results releaseAmended 1H24 Interim Report
HY25 / financial reportArborGen Holdings - Audited Financial Statements for year ended 31 March 2025
FY25 / financial reportRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 257.1% of EBITDA to operating cash flow, +677.1pp versus the prior comparable period.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Revenue growth context
Revenue growth was 7.6% for this reporting period.
Get the next ArborGen Holdings briefing and related NZX reporting-season updates by email.